157717-58-3 Usage
General Description
(S)-3-Azido-4,4-dimethyldihydrofuran-2(3H)-one is a chemical compound with the molecular formula C6H9N3O2. It is an azido-substituted dihydrofuranone, which is a type of organic compound. (S)-3-AZIDO-4,4-DIMETHYLDIHYDROFURAN-2(3H)-ONE is commonly used in the synthesis of various organic molecules and has been studied for its potential applications in medicinal chemistry and materials science. The azido group in the compound makes it suitable for use in click chemistry reactions, which are widely used in bioconjugation and materials science. Additionally, the unique structure of (S)-3-azido-4,4-dimethyldihydrofuran-2(3H)-one makes it a valuable building block for the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 157717-58-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,7,1 and 7 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 157717-58:
(8*1)+(7*5)+(6*7)+(5*7)+(4*1)+(3*7)+(2*5)+(1*8)=163
163 % 10 = 3
So 157717-58-3 is a valid CAS Registry Number.
157717-58-3Relevant articles and documents
Use of R-pantolactone in the synthesis of L-tert leucine derivatives
Freskos
, p. 557 - 563 (1994)
A 4 step synthesis of the N-Boc-β,β-Dimethyl Homoserine lactone from inexpensive, commercially available R-Pantolactone is described.
Structure-activity relationship of daptomycin analogues with substitution at (2S, 3R) 3-methyl glutamic acid position
Lin, Du'an,Lam, Hiu Yung,Han, Wenbo,Cotroneo, Nicole,Pandya, Bhaumik A.,Li, Xuechen
, p. 456 - 459 (2017/01/17)
Daptomycin is a highly effective lipopeptide antibiotic against Gram-positive pathogens. The presence of (2S, 3R) 3-methyl glutamic acid (mGlu) in daptomycin has been found to be important to the antibacterial activity. However the role of (2S, 3R) mGlu i
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
